The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.50
Bid: 42.00
Ask: 45.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.143%)
Open: 43.50
High: 43.50
Low: 43.50
Prev. Close: 43.50
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Feb 2014 16:49

RNS Number : 4018Z
Ebiquity PLC
05 February 2014
 



Ebiquity plc ("Ebiquity" or the "Company")

Holding in Company

 

Holding in Company

The Company was today notified by Veronis Suhler Stevenson ("VSS"), the Company's largest shareholder, that it has agreed to sell, through an institutional placing with Numis Securities Limited acting as bookrunner, 28,912,410 ordinary shares of 25p each ("Shares") in the Company, at a price of 120p per share, comprising 15,109,549 Shares that it currently holds ("VSS Shares") and 13,802,861 Shares that it will hold as a result of conversion in full of the convertible loan notes ("Loan Note") that it currently holds ("VSS Note Shares").

 

The VSS Shares and VSS Note Shares will settle in two tranches with the VSS Shares expected to settle on 13 February 2014 ("Tranche 1 Settlement") and the VSS Note Shares expected to settle on 20 February 2014 ("Tranche 2 Settlement").

 

VSS has issued to the Company a conditional exercise notice in relation to the Loan Note. On Tranche 1 Settlement, Numis will confirm to the Company the number of VSS Shares settled. Assuming the VSS Shares settle in full, following Tranche 1 Settlement VSS will not hold any Shares, and will therefore hold nil voting rights, in the Company. If the VSS Shares have settled in full, the exercise notice will become unconditional and the Company will issue the 13,802,861 VSS Note Shares to VSS in full conversion of the Loan Note and will apply for 13,802,861 Shares to be admitted to trading on AIM on 19 February 2014 ("Admission").

 

Upon Admission, the VSS Note Shares will rank pari passu in all respects with the existing Shares of the Company. Immediately following issue of the VSS Note Shares to VSS, it will hold 13,802,861 Shares being 19.6% of the voting rights of the Company. Following Tranche 2 Settlement, VSS will not hold any Shares (and will therefore hold nil voting rights in the Company) or any Loan Notes in the Company and it has been agreed that both VSS representatives, Christopher Russell (non-executive director) and Jeffrey Stevenson (non-executive director), will step down from the Board.

 

In the unlikely event that there is any default on Tranche 1 Settlement, VSS shall only be entitled to convert such proportion of the Loan Note as would result in them holding not more than 29.9% of the voting rights of the Company, when aggregated with their remaining shareholding following Tranche 1 Settlement. The Company will release an announcement on Tranche 1 Settlement to confirm the number of VSS Note Shares VSS is entitled to convert.

 

Total voting rights

Following Admission, the Company's issued share capital will consist of 74,346,174 ordinary shares of 25p each and a total of 70,146,174 voting rights.

 

Note 1

The Ebiquity plc 2000 Employee Benefit Trust holds 4,200,000 issued Shares to satisfy awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Shares held by it. As such 4,200,000 Shares are treated as not carrying voting rights for the purposes of the City Code on Takeovers and Mergers.

5 February 2014

ENQUIRIES:

Ebiquity

020 7650 9600

Michael Greenlees, CEO

Andrew Beach, CFO

Instinctif Partners

020 7457 2020

Matthew Smallwood

Jamie Ramsay

Numis Securities

020 7260 1000

Nick Westlake (NOMAD)

David Poutney, James Serjeant (Corporate Broker)

 

 

 

Numis, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is the Company's nominated adviser and broker. Numis' responsibilities as the Company's nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company or to any director of the Company or to any other person. Numis is acting as bookrunner for the sellers in the placings and other arrangements detailed in this announcement and will not be responsible to anyone other than those sellers for providing the protections afforded to its clients or for providing advice in relation to the content of this announcement or any matter, transaction or arrangement discussed or referred to in it.

 

The shares being sold pursuant to the placings described above have not been (and are not being) registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and are being sold (i) outside the United States in reliance on Regulation S under Securities Act and (ii) within the United States only to persons reasonably believed to be qualified institutional buyers within the meaning of and pursuant to Rule 144A under the Securities Act in transactions exempt from the registration requirements of the Securities Act.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSSDFMIFLSELE
Date   Source Headline
25th Apr 202211:38 amRNSNotification of major holdings
22nd Apr 20224:05 pmRNSANNUAL REPORT AND ANNUAL GENERAL MEETING
22nd Apr 202210:56 amRNSNotification of major holdings
22nd Apr 202210:51 amRNSNotification of major holdings
20th Apr 20225:47 pmRNSDirector/PDMR Shareholding
20th Apr 20224:56 pmRNSIssue of Shares and TVR
20th Apr 20228:05 amRNSCompletion of MediaPath Acquisition and TVR
19th Apr 202211:03 amRNSResult of General Meeting
5th Apr 20225:01 pmRNSStandard form for notification of major holdings
4th Apr 20228:06 amRNSCompletion of Acquisition and TVR
31st Mar 20227:00 amRNSPosting of Shareholder Circular and Notice of GM
30th Mar 20222:40 pmRNSResults of Placing
30th Mar 20227:02 amRNSProposed Acquisition of MediaPath and Placing
30th Mar 20227:01 amRNSFinal Results for the year ended 31 December 2021
30th Mar 20227:00 amRNSProposed Acquisition of Media Management, LLC.
25th Mar 202210:45 amRNSInvestor Presentation
17th Mar 20227:00 amRNSNotice of Results update
22nd Feb 20228:36 amRNSHolding(s) in Company
10th Feb 202211:50 amRNSIssue of Shares and TVR
2nd Feb 20223:55 pmRNSHolding(s) in Company
31st Jan 20222:00 pmRNSIssue of Shares and TVR
31st Jan 20227:00 amRNSTrading Update and Acquisition
25th Jan 20222:00 pmRNSHolding(s) in Company
11th Jan 20224:50 pmRNSHolding(s) in Company
25th Nov 202110:00 amRNSHolding(s) in Company
16th Nov 20214:35 pmRNSHolding(s) in Company
11th Nov 20211:30 pmRNSIssue of Shares and TVR
26th Oct 202110:05 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSNew office launch in India
8th Oct 20219:40 amRNSIssue of Shares
24th Sep 20215:55 pmRNSInterim Results - Replacement
23rd Sep 20217:00 amRNSInterim Results
1st Sep 202111:45 amRNSHolding(s) in Company
29th Jul 202111:30 amRNSIssue of Shares
13th Jul 20217:00 amRNSTrading update
28th May 202111:20 amRNSResult of AGM
24th May 202112:20 pmRNSHolding(s) in Company
30th Apr 20213:00 pmRNSDirectors’ Dealing
26th Apr 20217:00 amRNSAppointment of Non-Executive Director
21st Apr 20213:35 pmRNSAnnual Report and Accounts, Notice of AGM
6th Apr 202111:15 amRNSNotification of Transaction of Director
26th Mar 20214:20 pmRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSFinal Results
12th Mar 20217:00 amRNSAppointment of Nominated Adviser and Broker
15th Feb 20217:00 amRNSPre-close Trading Update
4th Jan 20218:00 amRNSTotal Voting Rights
8th Dec 20204:00 pmRNSIssue of Shares
25th Nov 202010:30 amRNSDirector/PDMR Shareholding
18th Nov 20208:00 amEQSEbiquity (EBQ): Digital acceleration
10th Nov 20207:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.